Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation

Tendon defects require multimodal therapeutic management over extensive periods and incur high collateral burden with frequent functional losses. Specific cell therapies have recently been developed in parallel to surgical techniques for managing acute and degenerative tendon tissue affections, to o...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurent, Alexis, Abdel-Sayed, Philippe, Grognuz, Anthony, Scaletta, Corinne, Hirt-Burri, Nathalie, Michetti, Murielle, de Buys Roessingh, Anthony S., Raffoul, Wassim, Kronen, Peter, Nuss, Katja, von Rechenberg, Brigitte, Applegate, Lee Ann, Darwiche, Salim E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066015/
https://www.ncbi.nlm.nih.gov/pubmed/33916829
http://dx.doi.org/10.3390/biomedicines9040380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066015/
https://www.ncbi.nlm.nih.gov/pubmed/33916829
http://dx.doi.org/10.3390/biomedicines9040380

Ejemplares similares